|
|
Volumn 125, Issue 20, 2015, Pages 3039-3040
|
|
Introduction to a series of reviews on multiple myeloma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
CARFILZOMIB;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
HISTONE DEACETYLASE INHIBITOR;
IXAZOMIB;
KINESIN INHIBITOR;
MELPHALAN;
MONOCLONAL ANTIBODY;
POMALIDOMIDE;
PREDNISONE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CANCER PROGNOSIS;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER SURVIVAL;
CANCER THERAPY;
CONSOLIDATION CHEMOTHERAPY;
CYTOGENETICS;
DENDRITIC CELL;
DRUG EFFICACY;
EDITORIAL;
GAMMOPATHY;
GENE DELETION;
GENE MUTATION;
GENETIC HETEROGENEITY;
GENOMICS;
HUMAN;
IMMUNOMODULATION;
IMMUNOSURVEILLANCE;
IMMUNOTHERAPY;
MAINTENANCE THERAPY;
MINIMAL RESIDUAL DISEASE;
MULTIPLE MYELOMA;
NATURAL KILLER CELL;
PATIENT MONITORING;
PRECANCER;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
TUMOR MICROENVIRONMENT;
HUMANS;
MULTIPLE MYELOMA;
|
|
EID: 84929321029
PISSN: 00064971
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2015-01-613596 Document Type: Editorial |
|
Times cited : (19)
|
|
References (0)
|
